World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
106
Citations
42467
World Ranking
6527
National Ranking
3466

Robert D. Cardiff publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Robert D. Cardiff sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 420 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Robert D. Cardiff D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Robert D. Cardiff sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 106 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2005 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Robert D. Cardiff is affiliated with the University of California, Davis in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with notable contributions in Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, and Neurology.

The scientist's work covers several key topics, including:

  • Cancer Cells and Metastasis
  • Cancer-related molecular mechanisms research
  • Barrier Structure and Function Studies
  • Prostate Cancer Treatment and Research
  • HER2/EGFR in Cancer Research
  • PI3K/AKT/mTOR signaling in cancer
  • Genetic factors in colorectal cancer

Robert D. Cardiff has contributed to several recent publications. Notable papers include:

  • Highly metastatic claudin-low mammary cancers can originate from luminal epithelial cells, 2021, Nature Communications
  • Environmental Exposures during Puberty: Window of Breast Cancer Risk and Epigenetic Damage, 2020, International Journal of Environmental Research and Public Health
  • Aberrant androgen action in prostatic progenitor cells induces oncogenesis and tumor development through IGF1 and Wnt axes, 2022, Nature Communications
  • HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase, 2021, Molecular Cancer Research
  • Rheb1-Independent Activation of mTORC1 in Mammary Tumors Occurs through Activating Mutations in mTOR, 2020, Cell Reports

Frequent collaborators include Charles M. Perou, Alexander D. Borowsky, Kay-Uwe Wagner, Patrick D. Rädler, and Aleata A. Triplett.

Robert D. Cardiff's publications have appeared regularly in journals and venues such as:

  • UNC Libraries
  • Cancer Research
  • Nature Communications
  • Molecular Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)

In recognition of their scientific contributions, Robert D. Cardiff was named a Fellow of the American Association for the Advancement of Science (AAAS) in 2005.

Best Publications

  • Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease.

    Chantale T. Guy;Robert D. Cardiff;William J. Muller

  • Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

    Chantale T. Guy;Marc A. Webster;Michael Schaller;Thomas J. Parsons

  • Mammary Hyperplasia and Carcinoma in MMTV-cyclin D1 Transgenic Mice

    Timothy C. Wang;Robert D. Cardiff;Lawrence Zukerberg;Emma Lees

  • MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer

    Catherine M. Shachaf;Andrew M. Kopelman;Constadina Arvanitis;Åsa Karlsson

  • The transcriptional repressor Snail promotes mammary tumor recurrence

    Susan E. Moody;Denise Perez;Tien-Chi Pan;Christopher J. Sarkisian

  • Roles for Nkx3.1 in prostate development and cancer

    Rajula Bhatia-Gaur;Annemarie A. Donjacour;Peter J. Sciavolino;Peter J. Sciavolino;Minjung Kim;Minjung Kim

  • Prostate Pathology of Genetically Engineered Mice: Definitions and Classification. The Consensus Report from the Bar Harbor Meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee

    Scott B. Shappell;George V. Thomas;Richard L. Roberts;Ron Herbert

  • Manual Hematoxylin and Eosin Staining of Mouse Tissue Sections

    Robert D. Cardiff;Claramae H. Miller;Robert J. Munn

  • Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis

    Patrick W.B. Derksen;Xiaoling Liu;Francis Saridin;Hanneke van der Gulden

  • PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms

    Daniel J. Freeman;Andrew G. Li;Gang Wei;Heng-Hong Li

  • Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer.

    Peter M. Siegel;Eamonn D. Ryan;Robert D. Cardiff;William J. Muller

  • The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting{

    Robert D Cardiff;Miriam R Anver;Barry A Gusterson;Lothar Hennighausen

  • Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis

    Jennifer C King;Jin Xu;John Wongvipat;Haley Hieronymus

  • Transforming growth factor β signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis

    Peter M. Siegel;Weiping Shu;Robert D. Cardiff;William J. Muller

  • c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations

    Celina M. D'Cruz;Edward J. Gunther;Robert B. Boxer;Jennifer L. Hartman

  • Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice.

    Scott C. Kogan;Jerrold M. Ward;Miriam R. Anver;Jules J. Berman

  • Protein kinase CK2 in mammary gland tumorigenesis.

    Esther Landesman-Bollag;Raphaëlle Romieu-Mourez;Diane H Song;Gail E Sonenshein

  • Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis

    Minjung J. Kim;Robert D. Cardiff;Nishita Desai;Nishita Desai;Whitney A. Banach-Petrosky;Whitney A. Banach-Petrosky

  • Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis

    Susan E Moody;Christopher J Sarkisian;Kristina T Hahn;Edward J Gunther

  • Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity

    Zhu A. Wang;Antonina Mitrofanova;Sarah K. Bergren;Cory Abate-Shen

Frequent Co-Authors

William J. Muller
William J. Muller McGill University
Cory Abate-Shen
Cory Abate-Shen Columbia University
Michael M. Shen
Michael M. Shen Columbia University
Jerrold M. Ward
Jerrold M. Ward National Institutes of Health
David C. Seldin
David C. Seldin Boston University
Philip Leder
Philip Leder Harvard University
Katherine W. Ferrara
Katherine W. Ferrara Stanford University
Robert G. Oshima
Robert G. Oshima Sanford Burnham Prebys Medical Discovery Institute
Lesley G. Ellies
Lesley G. Ellies University of California, San Diego
Senthil K. Muthuswamy
Senthil K. Muthuswamy Beth Israel Deaconess Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean committing to the traditional MD path. There are several online degree options that allow you to enter healthcare faster, specialize in key areas, or take on important non-clinical roles. Many students look for the shortest dnp program to advance their nursing careers quickly and efficiently, often while continuing to work.

For those seeking to enter nursing as soon as possible, accelerated lpn programs provide a pathway to begin working in the healthcare sector in less time than traditional programs. If you already hold a master’s degree, there are also options to further specialize, such as the shortest post master's pmhnp online programs that focus on psychiatric mental health.

Not all career pathways in healthcare are clinical. Many choose to focus on the business or administrative side, and a bachelors in health administration is a flexible online solution for those aiming to lead and innovate in hospitals, clinics, or public health. Explore these options for tailored pathways and quicker entry into the dynamic field of healthcare.

Best Scientists Citing Robert D. Cardiff

Trending Scientists

Recently Published Articles